IceCure Medical Stock Is On Fire After Hours: What's Going On?
IceCure Medical Stock Is On Fire After Hours: What's Going On?
Based on these interim results, it was concluded that cryoablation is safe and effective for treating renal masses under 5 centimeters.IceCure Medical Ltd (NASDAQ:ICCM) shares are soaring in Monday's after-hours session after the company announced interim results from the ICESECRET study for the treatment of patients with small renal masses who cannot be offered kidney-preserving surgery.
智健醫療有限公司 （NASDAQ：ICCM）在公司宣布了 ICESECRET 研究中期結果，該研究針對無法提供腎臟保存手術的小腎腫瘤患者的治療中期結果之後，股價在週一的營業時段飆升。
What Happened: IceCure said 107 of the 115 patients enrolled returned for follow-up with a mean duration of 22.8 months and a range of 12 to 60 months. The recurrence-free rate was 85.1% for the 107 patients at a mean follow-up period of 16.5 months.
發生了什麼事： IceCure 表示，在 115 名被招收的患者中，有 107 名返回跟進，平均持續時間為 22.8 個月，範圍為 12 至 60 個月。107 名患者在 16.5 個月的平均跟進期內，無復發率為 85.1%。
Five serious adverse events were reported, four of which were of mild severity. Cryoablation time and hospitalization time were relatively short, up to approximately 25 minutes and two days, respectively.
報告了五宗嚴重不良事件，其中四宗為輕微嚴重程度。冷凍消融時間和住院時間相對較短，分別長達約 25 分鐘和兩天。
Based on these interim results, it was concluded that cryoablation is safe and effective for treating renal masses under 5 centimeters.
根據這些中期結果，可以得出結論，冷凍消融對於治療 5 厘米以下的腎腫塊是安全有效的。
"We believe the findings will support further use of ProSense in the jurisdictions in which our cryoablation system is approved for use with benign and malignant tissues of the kidney," said Eyal Shamir, CEO of IceCure.
「我們相信這些研究結果將支持在我們的冷凍消融系統被批准用於腎臟良性和惡性組織的司法管轄區中進一步使用 ProSense。」 艾尔·沙米尔，ICeCure 的首席執行官。
IceCure develops and markets ProSense, an advanced liquid-nitrogen-based cryoablation therapy for the treatment of tumors by freezing.
IceCure 開發並銷售 ProSense，這是一種先進的基於液氮的冷凍消融療法，用於通過冷凍治療腫瘤。
See Also: Why Entrada Therapeutics Stock Is Diving After Hours
另請參閱： 為什麼恩特拉達治療學股票在下班後潛水
ICCM Price Action: IceCure shares are up 760.60% in after hours at $8.03 at the time of publication, according to Benzinga Pro.
ICCM 價格行動： 根據本辛加專業版的說法，IceCure 股票在發布時間上漲了 760.60％，在發布時間為 8.03 美元。
Photo: Dominik Fuchs from Pixabay.
照片： 多米尼克·福克斯 從皮克薩貝。
